Literature DB >> 18762941

Non-classical hereditary hemochromatosis in Portugal: novel mutations identified in iron metabolism-related genes.

Ana Isabel Mendes1, Ana Ferro, Rute Martins, Isabel Picanço, Susana Gomes, Rute Cerqueira, Manuel Correia, António Robalo Nunes, Jorge Esteves, Rita Fleming, Paula Faustino.   

Abstract

The most frequent genotype associated with Hereditary hemochromatosis is the homozygosity for C282Y, a common HFE mutation. However, other mutations in HFE, transferrin receptor 2 (TFR2), hemojuvelin (HJV) and hepcidin (HAMP) genes, have also been reported in association with this pathology. A mutational analysis of these genes was carried out in 215 Portuguese iron-overloaded individuals previously characterized as non-C282Y or non-H63D homozygous and non-compound heterozygous. The aim was to determine the influence of these genes in the development of iron overload phenotypes in our population. Regarding HFE, some known mutations were found, as S65C and E277K. In addition, three novel missense mutations (L46W, D129N and Y230F) and one nonsense mutation (Y138X) were identified. In TFR2, besides the I238M polymorphism and the rare IVS5 -9T-->A mutation, a novel missense mutation was detected (F280L). Concerning HAMP, the deleterious mutation 5'UTR -25G-->A was found once, associated with Juvenile Hemochromatosis. In HJV, the A310G polymorphism, the novel E275E silent alteration and the novel putative splicing mutation (IVS2 +395C-->G) were identified. In conclusion, only a few number of mutations which can be linked to iron overload was found, revealing their modest contribution for the development of this phenotype in our population, and suggesting that their screening in routine diagnosis is not cost-effective.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18762941     DOI: 10.1007/s00277-008-0572-y

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  8 in total

1.  Iron overload in HFE C282Y heterozygotes at first genetic testing: a strategy for identifying rare HFE variants.

Authors:  Patricia Aguilar-Martinez; Bernard Grandchamp; Séverine Cunat; Estelle Cadet; François Blanc; Marlène Nourrit; Kaiss Lassoued; Jean-François Schved; Jacques Rochette
Journal:  Haematologica       Date:  2011-01-12       Impact factor: 9.941

2.  A novel rat model of hereditary hemochromatosis due to a mutation in transferrin receptor 2.

Authors:  Thomas B Bartnikas; Sheryl J Wildt; Amy E Wineinger; Klaus Schmitz-Abe; Kyriacos Markianos; Dale M Cooper; Mark D Fleming
Journal:  Comp Med       Date:  2013-04       Impact factor: 0.982

Review 3.  Physiology of iron metabolism.

Authors:  Sophie Waldvogel-Abramowski; Gérard Waeber; Christoph Gassner; Andreas Buser; Beat M Frey; Bernard Favrat; Jean-Daniel Tissot
Journal:  Transfus Med Hemother       Date:  2014-05-12       Impact factor: 3.747

Review 4.  Ethnic Differences in Iron Status.

Authors:  Wanhui Kang; Alexa Barad; Andrew G Clark; Yiqin Wang; Xu Lin; Zhenglong Gu; Kimberly O O'Brien
Journal:  Adv Nutr       Date:  2021-10-01       Impact factor: 8.701

Review 5.  Molecular diagnostic and pathogenesis of hereditary hemochromatosis.

Authors:  Paulo C J L Santos; Jose E Krieger; Alexandre C Pereira
Journal:  Int J Mol Sci       Date:  2012-02-01       Impact factor: 6.208

6.  Alternative polyadenylation and nonsense-mediated decay coordinately regulate the human HFE mRNA levels.

Authors:  Rute Martins; Daniela Proença; Bruno Silva; Cristina Barbosa; Ana Luísa Silva; Paula Faustino; Luísa Romão
Journal:  PLoS One       Date:  2012-04-18       Impact factor: 3.240

7.  Brain iron accumulation affects myelin-related molecular systems implicated in a rare neurogenetic disease family with neuropsychiatric features.

Authors:  M Heidari; D M Johnstone; B Bassett; R M Graham; A C G Chua; M J House; J F Collingwood; C Bettencourt; H Houlden; M Ryten; J K Olynyk; D Trinder; E A Milward
Journal:  Mol Psychiatry       Date:  2016-01-05       Impact factor: 15.992

8.  A late presentation of a fatal disease: juvenile hemochromatosis.

Authors:  Cynthia Cherfane; Pauline Lee; Leana Guerin; Kyle Brown
Journal:  Case Rep Med       Date:  2013-09-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.